Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Stein, P. D.
space
  arrow  Raskob, G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Risks for Major Bleeding from Thrombolytic Therapy in Patients with Acute Pulmonary Embolism: Consideration of Noninvasive Management

right arrow Paul D. Stein; Russell D. Hull; and Gary Raskob

1 September 1994 | Volume 121 Issue 5 | Pages 313-317

Objective: To assess the relative risks for bleeding with thrombolytic therapy in patients who are managed using pulmonary angiograms compared with those managed using noninvasive tests, primarily the ventilation-perfusion lung scan.

Design: A decision analysis based on data from other studies.

Methods: The risk for major bleeding in patients with pulmonary embolism who receive thrombolytic therapy after a noninvasive diagnosis was assessed from complications of thrombolytic therapy in patients with myocardial infarction, assuming that the same risk ratio for major bleeding when comparing an invasive with a noninvasive approach applied to patients with pulmonary embolism. The risk ratio was 3.3 (95% CI, 1.5 to 9.8) for major bleeding in patients with myocardial infarction. One or more major complications of pulmonary angiography occurred in 1.3% of patients (CI, 0.6% to 1.9%).

Results: The average reported risk was 14% (18 of 129 patients) (CI, 7.9% to 20.1%) for major bleeding in patients who had pulmonary angiography before receiving tissue plasminogen activator (tPA). The estimated risk was 4.2% (estimated CI, 1.4% to 9.3%) for major bleeding with tPA after a noninvasive diagnosis of pulmonary embolism. Assuming a risk of 1.3% for major complications from pulmonary angiography, a risk for major hemorrhage of 14.0% for an invasive diagnosis, and a risk of 4.2% for a noninvasive diagnosis, fewer complications would occur with noninvasive management if the prevalence of pulmonary embolism exceeded 21%.

Conclusion: Among patients with suspected pulmonary embolism who are candidates for thrombolytic therapy, it is safer to use noninvasive diagnostic tests in many patients.

Author and Article Information
space

From the Henry Ford Heart and Vascular Institute, Detroit, Michigan.
Requests for Reprints: Paul D. Stein, MD, Henry Ford Hospital, New Center Pavilion—Room 1105, 2921 West Grand Boulevard, Detroit, MI 48202-2691.




This article has been cited by other articles:


Home page
Eur Heart JHome page
Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al.
Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Eur. Heart J., September 2, 2008; 29(18): 2276 - 2315.
[Full Text] [PDF]


Home page
CirculationHome page
S. Wan, D. J. Quinlan, G. Agnelli, and J. W. Eikelboom
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism: A Meta-Analysis of the Randomized Controlled Trials
Circulation, August 10, 2004; 110(6): 744 - 749.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
M. M. Behnia and O. W. Cummings
DESQUAMATIVE INTERSTITIAL PNEUMONIA MASQUERADING AS ACUTE LIFE-THREATENING PULMONARY EMBOLISM
Am. J. Crit. Care., May 1, 2004; 13(3): 199 - 201.
[Full Text] [PDF]


Home page
ChestHome page
K. E. Wood
Major Pulmonary Embolism : Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism
Chest, March 1, 2002; 121(3): 877 - 905.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
J H Reid
Out of hours radiological diagnosis of pulmonary embolism and deep venous thrombosis
Imaging, June 1, 2001; 13(2): 124 - 129.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Guidelines on diagnosis and management of acute pulmonary embolism
Eur. Heart J., August 2, 2000; 21(16): 1301 - 1336.
[PDF]


Home page
Vasc MedHome page
S. Z Goldhaber
A contemporary approach to thrombolytic therapy for pulmonary embolism
Vascular Medicine, May 1, 2000; 5(2): 115 - 123.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. Tapson
The Diagnostic Approach to Acute Venous Thromboembolism . Clinical Practice Guideline
Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 1043 - 1066.
[Full Text]


Home page
NEJMHome page
G. Simonneau, H. Sors, B. Charbonnier, Y. Page, J.-P. Laaban, R. Azarian, M. Laurent, J.-L. Hirsch, E. Ferrari, J.-L. Bosson, et al.
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism
N. Engl. J. Med., September 4, 1997; 337(10): 663 - 669.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1994 by the American College of Physicians.